"Combining our medical imaging business with Varian's capabilities will better position the business to support its customers and continue to innovate and develop new imaging systems," said Robert Friel, chairman and chief executive officer, PerkinElmer. "In addition, the divestiture will allow PerkinElmer to focus our investments and accelerate growth in higher priority areas."
The transaction is subject to customary closing conditions and is expected to close in the first half of 2017.
Perkinelmer, divest medical imaging business, varian medical